Bing Li
Beijing, 100700, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks.
Journal: Journal of translational medicine
Published: November 26, 2020
A Systems Approach to Refine Disease Taxonomy by Integrating Phenotypic and Molecular Networks.
Journal: EBioMedicine
Published: November 27, 2017
The Role of Chinese Herbal Medicines and Bioactive Ingredients Targeting Myocardial KCa and KATP Channels in Cardiovascular Diseases.
Journal: Current pharmaceutical design
Published: August 15, 2016
Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.
Journal: Hepatology international
Published: May 12, 2016
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
Journal: PloS one
Published: April 11, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 31, 2016
Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study.
Journal: Gut and liver
Published: July 12, 2015
Genetic association between CD44 polymorphisms and chronic hepatitis B virus infection in a Chinese Han population.
Journal: International journal of clinical and experimental pathology
Published: June 04, 2015
Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
Journal: International journal of oncology
Published: October 20, 2014
Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.
Journal: Experimental and therapeutic medicine
Published: October 11, 2014
Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 07, 2014
Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Journal: Diagnostic pathology
Published: August 26, 2014
Last Updated: 09/26/2026